---
title: "PMGC slips 2% in regular trading after earlier 29% surge on research plan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292344001.md"
description: "PMGC declines 2% to $1.04 after July 10's 29% surge on NorthStrive research plan; volume reaches 31.67M shares."
datetime: "2026-07-10T16:50:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292344001.md)
  - [en](https://longbridge.com/en/news/292344001.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292344001.md)
---

# PMGC slips 2% in regular trading after earlier 29% surge on research plan

PMGC(ELAB.US) 盘中现跌**1.89%**，现报**1.04 美元**。该股触发盘中 5 分钟急涨信号后回落，短期波动显著。

消息面上，07/10/2026 常规交易时段该股曾大涨**29%**至**1.369 美元**，主要受子公司 NorthStrive 计划开展独立流式细胞术研究以量化 EL-22 抗原的推动。当前成交量达**3166.66 万**股，反映资金博弈激烈。

### Related Stocks

- [ELAB.US](https://longbridge.com/en/quote/ELAB.US.md)

## Related News & Research

- [PMGC unit A&B Aerospace signs long-term supply agreement with PAD Group](https://longbridge.com/en/news/294060161.md)
- [PMGC unit NorthStrive signs exclusive FSU license to develop multi-domain drone payload technology](https://longbridge.com/en/news/292481384.md)
- [PMGC unit NorthStrive to launch independent FACS study to quantify EL-22 antigen expression](https://longbridge.com/en/news/292316283.md)
- [PMGC Holdings Subsidiary Secures Exclusive License for Aerospace and Defense Patent 12,291,334](https://longbridge.com/en/news/291979789.md)
- [PMGC unit NorthStrive Biosciences files two US patent applications for muscle preservation in GLP-1 weight loss market](https://longbridge.com/en/news/290190535.md)